Wharton Business Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8M Sell
232,139
-424
-0.2% -$63.1K 1.23% 23
2026
Q1
$34.1M Sell
232,563
-1,400
-0.6% -$216K 1.29% 22
2025
Q4
$36.2M Buy
233,963
+40
+0% +$5.99K 1.38% 21
2025
Q3
$32.6M Buy
233,923
+440
+0.2% +$59.5K 1.42% 21
2025
Q2
$31.6M Sell
233,483
-2,406
-1% -$325K 1.33% 22
2025
Q1
$34.4M Buy
235,889
+380
+0.2% +$55.2K 1.55% 20
2024
Q4
$32.4M Sell
235,509
-971
-0.4% -$142K 1.46% 20
2024
Q3
$36.4M Buy
236,480
+321
+0.1% +$48.7K 1.64% 19
2024
Q2
$34.4M Buy
236,159
+45
+0% +$6.46K 1.78% 17
2024
Q1
$34.9M Sell
236,114
-25,990
-10% -$3.73M 1.68% 18
2023
Q4
$35.7M Buy
262,104
+23,970
+10% +$3.12M 1.8% 14
2023
Q3
$30.7M Sell
238,134
-584
-0.2% -$77.5K 1.7% 16
2023
Q2
$31.7M Sell
238,718
-9,865
-4% -$1.3M 2.09% 13
2023
Q1
$32.2M Sell
248,583
-29,568
-11% -$3.86M 1.93% 12
2022
Q4
$37.8M Buy
278,151
+23,255
+9% +$3.08M 2.19% 12
2022
Q3
$30.9M Buy
254,896
+4,573
+2% +$589K 2.09% 12
2022
Q2
$32.1M Sell
250,323
-3,192
-1% -$418K 2.12% 12
2022
Q1
$34.7M Buy
253,515
+12,485
+5% +$1.65M 2.11% 14
2021
Q4
$34M Buy
241,030
+1,786
+0.7% +$237K 2.1% 14
2021
Q3
$30.5M Sell
239,244
-46,455
-16% -$6.14M 3.09% 8
2021
Q2
$36M Sell
285,699
-4,975
-2% -$610K 2.81% 10
2021
Q1
$33.9M Buy
290,674
+2,937
+1% +$339K 2.65% 11
2020
Q4
$32.6M Sell
287,737
-19,397
-6% -$2.12M 2.68% 11
2020
Q3
$32.4M Sell
307,134
-4,045
-1% -$426K 2.99% 10
2020
Q2
$31.1M Sell
311,179
-5,778
-2% -$570K 3% 10
2020
Q1
$28.1M Buy
316,957
+1,004
+0.3% +$97.5K 3.17% 9
2019
Q4
$32.2M Buy
315,953
+52,705
+20% +$5.07M 2.99% 10
2019
Q3
$23.7M Buy
263,248
+200
+0.1% +$18.3K 2.38% 13
2019
Q2
$24.4M Buy
263,048
+1,815
+0.7% +$163K 2.48% 14
2019
Q1
$24M Buy
261,233
+2,628
+1% +$237K 2.48% 14
2018
Q4
$22.4M Sell
258,605
-9,685
-4% -$877K 2.64% 12
2018
Q3
$25.5M Buy
268,290
+1,975
+0.7% +$178K 2.53% 13
2018
Q2
$22.2M Buy
266,315
+516
+0.2% +$42.8K 2.31% 16
2018
Q1
$21.6M Buy
265,799
+103,084
+63% +$8.78M 2.24% 17
2017
Q4
$13.4M Buy
162,715
+2,080
+1% +$171K 1.39% 22
2017
Q3
$13.1M Sell
160,635
-285
-0.2% -$22.9K 1.39% 22
2017
Q2
$12.8M Buy
160,920
+1,260
+0.8% +$96K 1.36% 22
2017
Q1
$11.9M Buy
159,660
+14,655
+10% +$1.07M 1.27% 22
2016
Q4
$10M Buy
145,005
+94,765
+189% +$6.58M 1.18% 24
2016
Q3
$3.62M Buy
50,240
+42,900
+584% +$3.16M 0.45% 45
2016
Q2
$526K Buy
+7,340
New +$517K 0.06% 94

Other funds holding XLV

Wharton Business Group's XLV Position: Q2 2026 in Review

Wharton Business Group reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.18% in Q2 2026, selling an estimated $63.1K and leaving 232,139 shares worth $36.8M. The position accounts for 1.23% of the portfolio, ranked #23.

Wharton Business Group first reported a position in XLV in Q2 2016 and has held it in 41 quarters since. The position peaked at $37.8M in Q4 2022. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Wharton Business Group held 232,139 shares of State Street Health Care Select Sector SPDR ETF worth $36.8M as of Q2 2026.
  • Wharton Business Group sold 424 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $63.1K.
  • State Street Health Care Select Sector SPDR ETF made up 1.23% of Wharton Business Group's portfolio in Q2 2026, its #23 holding.
  • Wharton Business Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2016 and has held it in 41 quarters since.
  • Wharton Business Group's State Street Health Care Select Sector SPDR ETF position peaked at $37.8M in Q4 2022.
  • 1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Wharton Business Group's 13F filing for Q2 2026, filed 10 Aug 2026.